α-Keto amides as inhibitors of histone deacetylase

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 19, 2003, Pages 3331-3335

  Wada, Carol K ^a   Frey, Robin R ^a   Ji, Zhiqin ^a   Curtin, Michael L ^a   Garland, Robert B ^a   Holms, James H ^a   Li, Junling ^a   Pease, Lori J ^a   Guo, Jun ^a   Glaser, Keith B ^a   Marcotte, Patrick A ^a   Richardson, Paul L ^a   Murphy, Shannon S ^a   Bouska, Jennifer J ^a   Tapang, Paul ^a   Magoc, Terrance J ^a   Albert, Daniel H ^a   Davidsen, Steven K ^a   Michaelides, Michael R ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDE; ESTER DERIVATIVE; HISTONE DEACETYLASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG POTENCY; ENZYME ISOLATION; IN VIVO STUDY; INHIBITION KINETICS; MOUSE; NONHUMAN; TUMOR; TUMOR MODEL;

EID: 10744230376     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(03)00685-1     Document Type: Article

References (21)

1. Jenuwein T., Allis C.D. Science. 293:2001;1074.
2. Review: Johnstone R.W. Nat. Rev. Drug Discov. 1:2002;287.
3. (a) Tsuji N., Kobayashi M., Nagashima K., Wakisaka Y., Koizumi K. J. Antibiotics. 29:1976;1.
4. (b) Yoshida M., Nomura S., Beppu T. Cancer Res. 47:1987;3688.
5. 50 value determined using immunoprecipitated HDAC1. Richon V.M., Emiliani S., Verdin E., Webb Y., Breslow R., Rifkind R.A., Marks P.A. Proc. Natl. Acad. Sci. U.S.A. 95:1998;3003.
6. 11
7. (b) Saito A., Yamashita T., Mariko Y., Nosaka Y., Tsuchiya K., Ando T., Suzuki T., Tsuruo T., Nakanishi O. Proc. Natl. Acad. Sci. U.S.A. 96:1999;4592.
8. Finnin M.S., Donigian J.R., Cohen A., Richon V.M., Rifkind R.A., Marks P.A., Breslow R., Pavletich N.P. Nature. 401:1999;188.
9. Curtin, M. L.; Garland, R. B.; Frey, R. R.; Heyman, H. R.; Michaelides, M. R.; Li, J.; Pease, L. J.; Glaser, K. B.; Marcotte, P. A.; Davidsen, S. K. Abstracts of Papers, 224th National Meeting of the American Chemical Society, Boston, MA, Aug. 18-22, 2002; MEDI 124.
10. Gelb M.H., Svaren J.P., Abeles R.H. Biochemistry. 24:1985;1813.
11. Chiou A., Markidis T., Constantinou-Kokotou V., Verger R., Kokotos G. Org. Lett. 2:2000;347.
12. Li Z., Patil G.S., Golubski Z.E., Hori H., Tehrani K., Foreman J.E., Eveleth D.D., Bartus R.T., Powers J.C. J. Med. Chem. 36:1993;3472.
13. Walter M.W., Felici A., Galleni M., Soto R.P., Adlington R.M., Baldwin J.E., Frère J.-M., Gololobov M., Shofield C.J. Bioorg. Med. Chem. Lett. 6:1996;2455.
14. Frey R.R., Wada C.K., Garland R.B., Curtin M.L., Michaelides M.R., Li J., Pease L.J., Glaser K.B., Marcotte P.A., Bouska J.J., Murphy S.S., Davidsen S.K. Bioorg. Med. Chem. Lett. 12:2002;3443.
15. Davis F.A., Vishwakarma L.C., Billmers J.G., Finn J. J. Org. Chem. 49:1984;3241.
16. Nakamura E. Tetrahedron Lett. 22:1981;663.
17. 50 value was determined using a mixture of HDAC1 and HDAC2 prepared from nuclear extraction of K562 erythroleukemia cells. This protocol is described in: Yoshida M., Kijima M., Akita M., Beppu T. J. Biol. Chem. 265:1990;17174.
18. Protocol described in ref 15 of Dai, Y.; Guo, Y.; Guo, J.; Pease, L. J.; Li, J.; Marcotte, P. A.; Glaser, K. B.; Tapangm P.; Albert, D. H.; Richardson, P. L.; Davidsen, S. K.; Michaelides, M. R. Bioorg. Med. Chem. Lett. 2003, 13, 1897.
19. Protocol described in ref 19 in Curtin M.L., Garland R.B., Heyman H.R., Frey R.R., Michaelides M.R., Li J., Pease L.J., Glaser K.B., Marcotte P.A., Davidsen S.K. Bioorg. Med. Chem. Lett. 12:2002;2919.
20. Protocol described in ref 20 in Curtin M.L., Garland R.B., Heyman H.R., Frey R.R., Michaelides M.R., Li J., Pease L.J., Glaser K.B., Marcotte P.A., Davidsen S.K. Bioorg. Med. Chem. Lett. 12:2002;2919.
21. Albert, D. H.; Davidsen, S. K. In Current Protocols in Pharmacology; Enna, S. J., Williams, M., Ferkany, J. W., Kenakin, T., Porsolt, R. D., Sullivan, J. P., Eds.; John Wiley & Sons: New York, 2001; p 5.23.1.